Financial Ratios

NURECA LTD.

NSE : NURECABSE : 543264ISIN CODE : INE0DSF01015Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE276.60-5.65 (-2 %)
PREV CLOSE ( ) 282.25
OPEN PRICE ( ) 283.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4374
TODAY'S LOW / HIGH ( )275.00 285.00
52 WK LOW / HIGH ( )252.4 468.25
NSE276.30-2.45 (-0.88 %)
PREV CLOSE( ) 278.75
OPEN PRICE ( ) 284.90
BID PRICE (QTY) 276.30 (140)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 19372
TODAY'S LOW / HIGH( ) 275.35 284.95
52 WK LOW / HIGH ( )253.5 468.8
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-8.4245.3146.536410.0020.75
   CEPS(Rs)-6.1246.7446.94969.143.42
   DPS(Rs)0.003.002.000.000.00
   Book NAV/Share(Rs)195.26203.74163.2913970.0044.63
   Tax Rate(%)23.1426.1225.5425.6627.61
Margin Ratios
   Core EBITDA Margin(%)-13.1420.6527.449.764.38
   EBIT Margin(%)-8.9822.9728.519.454.28
   Pre Tax Margin(%)-9.3522.7027.808.673.93
   PAT Margin (%)-7.1916.7720.706.452.85
   Cash Profit Margin (%)-5.2217.3020.886.823.29
Performance Ratios
   ROA(%)-3.6920.0139.7336.512.56
   ROE(%)-4.2224.6952.5091.4861.47
   ROCE(%)-5.2533.6167.7476.0092.41
   Asset Turnover(x)0.511.191.925.660.90
   Sales/Fixed Asset(x)10.4236.1395.73165.5412.11
   Working Capital/Sales(x)0.671.401.394.28-52.67
Efficiency Ratios
   Fixed Capital/Sales(x)0.100.030.010.010.08
   Receivable days11.122.0910.6523.9167.59
   Inventory Days149.5367.5243.1931.68241.47
   Payable days22.7118.5226.8419.96528.63
Valuation Parameters
   PER(x)0.0030.0712.940.000.00
   PCE(x)-49.0729.1512.830.000.00
   Price/Book(x)1.546.693.690.000.00
   Yield(%)0.000.220.33
   EV/Net Sales(x)2.065.012.240.10-0.10
   EV/Core EBITDA(x)-28.0520.157.390.99-2.15
   EV/EBIT(x)-21.9220.617.441.03-2.37
   EV/CE(x)1.135.072.380.29-0.06
   M Cap / Sales2.685.332.820.000.00
Growth Ratio
   Net Sales Growth(%)-56.2119.79114.560.0023.85
   Core EBITDA Growth(%)-112.95-1.56560.380.0038.89
   EBIT Growth(%)-116.96-3.17582.320.0031.28
   PAT Growth(%)-118.59-2.63625.960.0032.66
   EPS Growth(%)-118.59-2.63-99.270.0032.66
Financial Stability Ratios
   Total Debt/Equity(x)0.010.010.010.690.00
   Current Ratio(x)21.355.295.783.460.99
   Quick Ratio(x)17.543.894.691.720.31
   Interest Cover(x)-24.4284.9040.1312.2012.32
   Total Debt/Mcap(x)0.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.